Skip to main content
Top
Published in: Globalization and Health 1/2014

Open Access 01-12-2014 | Research

A systematic mapping of funders of maternal health intervention research 2000-2012

Authors: Katharine Footman, Matthew Chersich, Duane Blaauw, Oona MR Campbell, Ashar Dhana, Josephine Kavanagh, Mari Dumbaugh, Siphiwe Thwala, Leon Bijlmakers, Emily Vargas, Elinor Kern, Francisco Becerra, Loveday Penn-Kekana

Published in: Globalization and Health | Issue 1/2014

Login to get access

Abstract

Background

The priorities of research funding bodies govern the research agenda, which has important implications for the provision of evidence to inform policy. This study examines the research funding landscape for maternal health interventions in low- and middle-income countries (LMICs).

Methods

This review draws on a database of 2340 academic papers collected through a large-scale systematic mapping of research on maternal health interventions in LMICs published from 2000-2012. The names of funders acknowledged on each paper were extracted and categorised into groups. It was noted whether support took a specific form, such as staff fellowships or drugs. Variations between funder types across regions and topics of research were assessed.

Results

Funding sources were only reported in 1572 (67%) of articles reviewed. A high number of different funders (685) were acknowledged, but only a few dominated funding of published research. Bilateral funders, national research agencies and private foundations were most prominent, while private companies were most commonly acknowledged for support `in kind'. The intervention topics and geographic regions of research funded by the various funder types had much in common, with HIV being the most common topic and sub-Saharan Africa being the most common region for all types of funder. Publication outputs rose substantially for several funder types over the period, with the largest increase among bilateral funders.

Conclusions

A considerable number of organisations provide funding for maternal health research, but a handful account for most funding acknowledgements. Broadly speaking, these organisations address similar topics and regions. This suggests little coordination between funding agencies, risking duplication and neglect of some areas of maternal health research, and limiting the ability of organisations to develop the specialised skills required for systematically addressing a research topic. Greater transparency in reporting of funding is required, as the role of funders in the research process is often unclear.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sridhar D: Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Med. 2012, 9 (9): e1001312-10.1371/journal.pmed.1001312.PubMedPubMedCentralCrossRef Sridhar D: Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Med. 2012, 9 (9): e1001312-10.1371/journal.pmed.1001312.PubMedPubMedCentralCrossRef
2.
go back to reference Lee K, Mills A: Strengthening governance for global health research. BMJ. 2000, 321 (7264): 775-6. 10.1136/bmj.321.7264.775. PubMed PMID: 11009495. Pubmed Central PMCID: 1118594PubMedPubMedCentralCrossRef Lee K, Mills A: Strengthening governance for global health research. BMJ. 2000, 321 (7264): 775-6. 10.1136/bmj.321.7264.775. PubMed PMID: 11009495. Pubmed Central PMCID: 1118594PubMedPubMedCentralCrossRef
3.
go back to reference World Health Organization. Research and development to meet health needs in developing countries: strengthening global financing and coordination: report of the consultative expert working group on research and development: financing and coordination. 2012. World Health Organization. Research and development to meet health needs in developing countries: strengthening global financing and coordination: report of the consultative expert working group on research and development: financing and coordination. 2012.
4.
go back to reference Leroy JL, Habicht J-P, Pelto G, Bertozzi SM: Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health. 2007, 97 (2): 219-23. 10.2105/AJPH.2005.083287.PubMedPubMedCentralCrossRef Leroy JL, Habicht J-P, Pelto G, Bertozzi SM: Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health. 2007, 97 (2): 219-23. 10.2105/AJPH.2005.083287.PubMedPubMedCentralCrossRef
6.
7.
go back to reference Shiffman J: Has donor prioritization of HIV/AIDS displaced aid for other health issues?. Health Policy Plan. 2008, 23 (2): 95-100. 10.1093/heapol/czm045.PubMedCrossRef Shiffman J: Has donor prioritization of HIV/AIDS displaced aid for other health issues?. Health Policy Plan. 2008, 23 (2): 95-100. 10.1093/heapol/czm045.PubMedCrossRef
8.
go back to reference Sridhar D, Batniji R: Misfinancing global health: a case for transparency in disbursements and decision making. Lancet. 2008, 372 (9644): 1185-91. 10.1016/S0140-6736(08)61485-3.PubMedCrossRef Sridhar D, Batniji R: Misfinancing global health: a case for transparency in disbursements and decision making. Lancet. 2008, 372 (9644): 1185-91. 10.1016/S0140-6736(08)61485-3.PubMedCrossRef
9.
go back to reference Pokhrel S, Reidpath D, Allotey P: Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: a case study of Bill and Melinda Gates Foundation. Health Res Policy Syst. 2011, 9 (1): 2-10.1186/1478-4505-9-2.PubMedPubMedCentralCrossRef Pokhrel S, Reidpath D, Allotey P: Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: a case study of Bill and Melinda Gates Foundation. Health Res Policy Syst. 2011, 9 (1): 2-10.1186/1478-4505-9-2.PubMedPubMedCentralCrossRef
10.
go back to reference Moran M, Guzman J, Ropars A-L, McDonald A, Jameson N, Omune B, Ryan S, Wu L: Neglected disease research and development: how much are we really spending?. PLoS Med. 2009, 6 (2): e1000030-10.1371/journal.pmed.1000030.PubMedCentralCrossRef Moran M, Guzman J, Ropars A-L, McDonald A, Jameson N, Omune B, Ryan S, Wu L: Neglected disease research and development: how much are we really spending?. PLoS Med. 2009, 6 (2): e1000030-10.1371/journal.pmed.1000030.PubMedCentralCrossRef
11.
go back to reference Pitt C, Greco G, Powell-Jackson T, Mills A: Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003-08. Lancet. 2010, 376 (9751): 1485-96. 10.1016/S0140-6736(10)61302-5.PubMedCrossRef Pitt C, Greco G, Powell-Jackson T, Mills A: Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003-08. Lancet. 2010, 376 (9751): 1485-96. 10.1016/S0140-6736(10)61302-5.PubMedCrossRef
12.
go back to reference Financing Global Health 2009: Tracking Development Assistance for Health. 2009, IHME, Seattle, WA Financing Global Health 2009: Tracking Development Assistance for Health. 2009, IHME, Seattle, WA
14.
go back to reference Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Akena D, Alasfoor D, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Al Kahbouri MJ, Alla F, Allen PJ, et al: Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2014, 384 (9947): 980-1004. 10.1016/S0140-6736(14)60696-6. PubMed PMID: 24797575PubMedPubMedCentralCrossRef Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Akena D, Alasfoor D, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Al Kahbouri MJ, Alla F, Allen PJ, et al: Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2014, 384 (9947): 980-1004. 10.1016/S0140-6736(14)60696-6. PubMed PMID: 24797575PubMedPubMedCentralCrossRef
15.
go back to reference Global Health Visions: U.S Maternal Health Donors: A Landscape Analysis. Global Health Visions. 2011. Global Health Visions: U.S Maternal Health Donors: A Landscape Analysis. Global Health Visions. 2011.
17.
go back to reference Rottingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, Guzman J, Edwards D, Matlin SA, Terry RF: Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?. Lancet. 2013, 382 (9900): 1286-307. 10.1016/S0140-6736(13)61046-6. PubMed PMID: 23697824PubMedCrossRef Rottingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, Guzman J, Edwards D, Matlin SA, Terry RF: Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?. Lancet. 2013, 382 (9900): 1286-307. 10.1016/S0140-6736(13)61046-6. PubMed PMID: 23697824PubMedCrossRef
18.
go back to reference Fisk NM, McKee M, Atun R: Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop Med Int Health. 2011, 16 (6): 662-8. 10.1111/j.1365-3156.2011.02778.x. PubMed PMID: 21470349PubMedCrossRef Fisk NM, McKee M, Atun R: Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop Med Int Health. 2011, 16 (6): 662-8. 10.1111/j.1365-3156.2011.02778.x. PubMed PMID: 21470349PubMedCrossRef
19.
go back to reference Fisk NM, Atun R: Systematic analysis of research underfunding in maternal and perinatal health. BJOG. 2009, 116 (3): 347-56. 10.1111/j.1471-0528.2008.02027.x. PubMed PMID: 19187366PubMedCrossRef Fisk NM, Atun R: Systematic analysis of research underfunding in maternal and perinatal health. BJOG. 2009, 116 (3): 347-56. 10.1111/j.1471-0528.2008.02027.x. PubMed PMID: 19187366PubMedCrossRef
21.
go back to reference Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, Omune B, Ryan S, Wu L: Neglected disease research and development: how much are we really spending?. PLoS Med. 2009, 6 (2): e30-10.1371/journal.pmed.1000030. PubMed PMID: 19192946. Pubmed Central PMCID: 2634791PubMedCrossRef Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, Omune B, Ryan S, Wu L: Neglected disease research and development: how much are we really spending?. PLoS Med. 2009, 6 (2): e30-10.1371/journal.pmed.1000030. PubMed PMID: 19192946. Pubmed Central PMCID: 2634791PubMedCrossRef
22.
go back to reference Macroeconomics and Health: Investing in Health for Economic Development. 2001, World Health Organization, Geneva Macroeconomics and Health: Investing in Health for Economic Development. 2001, World Health Organization, Geneva
23.
go back to reference McCoy D, Kembhavi G, Patel J, Luintel A: The Bill & Melinda Gates Foundation's grant-making programme for global health. Lancet. 2009, 373 (9675): 1645-53. 10.1016/S0140-6736(09)60571-7.PubMedCrossRef McCoy D, Kembhavi G, Patel J, Luintel A: The Bill & Melinda Gates Foundation's grant-making programme for global health. Lancet. 2009, 373 (9675): 1645-53. 10.1016/S0140-6736(09)60571-7.PubMedCrossRef
25.
go back to reference Viergever RF: The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Global Health Action. 2013, 6: 22450-10.3402/gha.v6i0.22450. PubMed PMID: 24119660. Pubmed Central PMCID: 3796018PubMedCrossRef Viergever RF: The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Global Health Action. 2013, 6: 22450-10.3402/gha.v6i0.22450. PubMed PMID: 24119660. Pubmed Central PMCID: 3796018PubMedCrossRef
26.
go back to reference McCoy D, Chand S, Sridhar D: Global health funding: how much, where it comes from and where it goes. Health Policy Plan. 2009, 24 (6): 407-17. 10.1093/heapol/czp026.PubMedCrossRef McCoy D, Chand S, Sridhar D: Global health funding: how much, where it comes from and where it goes. Health Policy Plan. 2009, 24 (6): 407-17. 10.1093/heapol/czp026.PubMedCrossRef
27.
go back to reference Vartanian LR, Schwartz MB, Brownell KD: Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health. 2007, 97 (4): 667-75. 10.2105/AJPH.2005.083782.PubMedPubMedCentralCrossRef Vartanian LR, Schwartz MB, Brownell KD: Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health. 2007, 97 (4): 667-75. 10.2105/AJPH.2005.083782.PubMedPubMedCentralCrossRef
28.
go back to reference Levine J, Gussow J, Hastings D, Eccher A: Authors’ financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health. 2003, 93: 664-9. 10.2105/AJPH.93.4.664.PubMedPubMedCentralCrossRef Levine J, Gussow J, Hastings D, Eccher A: Authors’ financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health. 2003, 93: 664-9. 10.2105/AJPH.93.4.664.PubMedPubMedCentralCrossRef
29.
go back to reference What has the Gates Foundation done for global health?. Lancet. 2009, 373: 1577-10.1016/S0140-6736(09)60885-0. What has the Gates Foundation done for global health?. Lancet. 2009, 373: 1577-10.1016/S0140-6736(09)60885-0.
30.
go back to reference Stuckler D, Basu S, McKee M: Global health philanthropy and institutional relationships: how should conflicts of interest be addressed?. PLoS Med. 2011, 8 (4): e1001020-10.1371/journal.pmed.1001020.PubMedPubMedCentralCrossRef Stuckler D, Basu S, McKee M: Global health philanthropy and institutional relationships: how should conflicts of interest be addressed?. PLoS Med. 2011, 8 (4): e1001020-10.1371/journal.pmed.1001020.PubMedPubMedCentralCrossRef
31.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Prev Med. 2007, 45: 247-251. 10.1016/j.ypmed.2007.08.012.PubMedCrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Prev Med. 2007, 45: 247-251. 10.1016/j.ypmed.2007.08.012.PubMedCrossRef
Metadata
Title
A systematic mapping of funders of maternal health intervention research 2000-2012
Authors
Katharine Footman
Matthew Chersich
Duane Blaauw
Oona MR Campbell
Ashar Dhana
Josephine Kavanagh
Mari Dumbaugh
Siphiwe Thwala
Leon Bijlmakers
Emily Vargas
Elinor Kern
Francisco Becerra
Loveday Penn-Kekana
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2014
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-014-0072-x

Other articles of this Issue 1/2014

Globalization and Health 1/2014 Go to the issue